180 related articles for article (PubMed ID: 8241322)
1. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.
Fynan TM; Reiss M
Crit Rev Oncog; 1993; 4(5):493-540. PubMed ID: 8241322
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
3. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
4. Role of transforming growth factor beta in cancer.
Pasche B
J Cell Physiol; 2001 Feb; 186(2):153-68. PubMed ID: 11169452
[TBL] [Abstract][Full Text] [Related]
5. Effect of TGF-beta 1, TGF-alpha, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture.
Ilio KY; Sensibar JA; Lee C
J Androl; 1995; 16(6):482-90. PubMed ID: 8867596
[TBL] [Abstract][Full Text] [Related]
6. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
7. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta and suppression of carcinogenesis.
Sporn MB; Roberts AB; Wakefield LM; Glick AB; Danielpour D
Princess Takamatsu Symp; 1989; 20():259-66. PubMed ID: 2562184
[TBL] [Abstract][Full Text] [Related]
11. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD
J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135
[TBL] [Abstract][Full Text] [Related]
12. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
Stolz DB; Michalopoulos GK
J Cell Physiol; 1997 Jan; 170(1):57-68. PubMed ID: 9012785
[TBL] [Abstract][Full Text] [Related]
13. TGF beta regulation of cell proliferation.
Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
Borger DR; Mi Y; Geslani G; Zyzak LL; Batova A; Engin TS; Pirisi L; Creek KE
Virology; 2000 May; 270(2):397-407. PubMed ID: 10792999
[TBL] [Abstract][Full Text] [Related]
15. [Transforming growth factor beta. A potent multifunctional growth factor for normal and malignant cells].
Nørgaard P; Damstrup L; Spang-Thomsen M; Poulsen HS
Ugeskr Laeger; 1992 Nov; 154(49):3494-8. PubMed ID: 1334294
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
[TBL] [Abstract][Full Text] [Related]
17. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
18. Media acidification inhibits TGF beta-mediated growth suppression in cultured rabbit proximal tubule cells.
Tovbin D; Franch HA; Alpern RJ; Preisig PA
Proc Assoc Am Physicians; 1997 Nov; 109(6):572-9. PubMed ID: 9394419
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta and cancer: a love-hate relationship?
Reiss M
Oncol Res; 1997; 9(9):447-57. PubMed ID: 9495450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
